Chemoresistance is one of the major challenges for the breast cancer treatment. Owing to its
heterogeneous nature, the chemoresistance mechanisms of breast cancer are complicated …

Simple Summary Internationally, in women, breast cancer (BC) is the most common cancer
type and is the leading cause of cancer-related death. There are two main histological …

Breast cancer is the most common type of cancer found in women and today represents a
significant challenge to public health. With the latest breakthroughs in molecular biology and …

The incidence and mortality of breast cancer (BC) have increased in recent years, and BC is
the main cause of cancer-related death in women worldwide. One of the most significant …

Our understanding of breast cancer and its therapeutic approach has improved greatly due
to the advancement of molecular biology in recent years. Clinically, breast cancers are …

Breast cancer is the most common malignant tumor in females worldwide. Chemotherapy is
the standard breast cancer treatment; however, chemoresistance is often seen in patients …

Breast cancer (BC) affects over 250,000 women in the US each year. Drug-resistant cancer
cells are responsible for most breast cancer fatalities. Scientists are developing novel …

Breast cancer is the second leading cause of cancer death in women, affecting 1.7 million
patients every year worldwide. As a result of its heterogeneous nature, the genetic profile …

Chemotherapy is an essential treatment for breast cancer, inducing cancer cell death.
However, chemoresistance is a problem that limits the effectiveness of chemotherapy. Many …

Breast cancer has an extremely high incidence in women, and its morbidity and mortality
rank first among female tumors. With the increasing development of medicine today, the …